D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
-10.3%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$61.5B
AUM Growth
-$14.6B
Cap. Flow
-$10.1B
Cap. Flow %
-16.36%
Top 10 Hldgs %
10.78%
Holding
4,727
New
431
Increased
1,418
Reduced
1,362
Closed
552

Sector Composition

1 Technology 17.19%
2 Financials 14.3%
3 Healthcare 10.79%
4 Consumer Discretionary 9.85%
5 Industrials 7.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALL icon
3226
Allstate
ALL
$53.4B
$203K ﹤0.01%
+1,600
New +$203K
CIG icon
3227
CEMIG Preferred Shares
CIG
$5.84B
$203K ﹤0.01%
130,961
-84,288
-39% -$131K
BSRR icon
3228
Sierra Bancorp
BSRR
$416M
$202K ﹤0.01%
9,278
-14,660
-61% -$319K
FORM icon
3229
FormFactor
FORM
$2.36B
$202K ﹤0.01%
+5,212
New +$202K
NGNE icon
3230
Neurogene
NGNE
$287M
$202K ﹤0.01%
9,821
+1,215
+14% +$25K
PCSB
3231
DELISTED
PCSB Financial Corporation
PCSB
$200K ﹤0.01%
10,479
-15,263
-59% -$291K
XBIT icon
3232
XBiotech
XBIT
$86M
$199K ﹤0.01%
+35,330
New +$199K
TVRD
3233
Tvardi Therapeutics, Inc. Common Stock
TVRD
$332M
$198K ﹤0.01%
601
-953
-61% -$314K
JELD icon
3234
JELD-WEN Holding
JELD
$566M
$196K ﹤0.01%
+13,431
New +$196K
AWF
3235
AllianceBernstein Global High Income Fund
AWF
$967M
$195K ﹤0.01%
20,000
REI icon
3236
Ring Energy
REI
$211M
$195K ﹤0.01%
+73,218
New +$195K
DHC
3237
Diversified Healthcare Trust
DHC
$1.09B
$194K ﹤0.01%
106,739
-225,324
-68% -$410K
DAVE icon
3238
Dave Inc
DAVE
$3.04B
$190K ﹤0.01%
8,630
+6,700
+347% +$148K
SRRK icon
3239
Scholar Rock
SRRK
$3.06B
$188K ﹤0.01%
+34,228
New +$188K
ADV icon
3240
Advantage Solutions
ADV
$619M
$187K ﹤0.01%
+49,083
New +$187K
ALGS icon
3241
Aligos Therapeutics
ALGS
$75.6M
$187K ﹤0.01%
6,195
+5,364
+645% +$162K
SNCR icon
3242
Synchronoss Technologies
SNCR
$66.8M
$187K ﹤0.01%
18,149
+6,243
+52% +$64.3K
GTES icon
3243
Gates Industrial
GTES
$6.71B
$186K ﹤0.01%
+17,212
New +$186K
LFLY
3244
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$186K ﹤0.01%
+2,065
New +$186K
ACTG icon
3245
Acacia Research
ACTG
$314M
$185K ﹤0.01%
+36,723
New +$185K
ASLE icon
3246
AerSale
ASLE
$415M
$184K ﹤0.01%
12,677
TLPH icon
3247
Talphera
TLPH
$20.4M
$183K ﹤0.01%
37,429
-153,021
-80% -$748K
ZEV.WS
3248
DELISTED
Lightning eMotors, Inc. Redeemable Warrants, each whole warrant exercisable 1/20th of a share of common stock at an exercise price of $230.00 per whole share
ZEV.WS
$183K ﹤0.01%
434,782
ISEE
3249
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$183K ﹤0.01%
+19,063
New +$183K
CS
3250
DELISTED
Credit Suisse Group
CS
$183K ﹤0.01%
32,267
-659,599
-95% -$3.74M